Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.73 |
| ▸ | HNF4A | P41235 | 2/20 | 0.73 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.70 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.70 |
| ▸ | APP | P05067 | 5/20 | 0.68 |
| ▸ | LCK | P06239 | 1/20 | 0.66 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | PIM1 | P11309 | 1/20 | 0.49 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | DHFR | P00374 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8229438 | 1.00 | PTPN1 (0.73) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL8229587 | 0.89 | PTPN1 (0.81) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL7893782 | 0.88 | PTPN1 (0.66) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL7709291 | 0.86 | PTPN1 (0.76) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL21385358 | 0.85 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL30075246 | 0.85 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL673426 | 0.85 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL6266631 | 0.83 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL1048686 | 0.83 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP | |
| SCHEMBL6266629 | 0.83 | PTPN1 (1.00) | PTPN1HNF4APTPN2PTPN6APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417178-B1 | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits | UNIVERSITY OF PITTSBURGH | 2002-07-09 | — | — | US | disclosed |
| US-6168776-B1 | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | UNIVERSITY OF PITTSBURGH | 2001-01-02 | — | — | US | disclosed |
| US-6133259-A | DIAGNOSIS OF ALZHEIMER'S DISEASE | UNIVERSITY OF PITTSBURGH (US) | 2000-10-17 | — | — | US | disclosed |
| US-6114175-A | AMYLOID-BINDING COMPOUNDS WHICH ARE NON-AZO DERIVATIVES OF CHRYSAMINE G TO DETERMINE DEGREE OF BRAIN DEPOSITS QUANTITATIVELY CHARACTERIZED BY AMYLOIDOSIS; DOWN'S SYNDROME; PREVENT CELL DEGENERATION; RADIOACTIVE IMAGING | UNIVERSITY OF PITTSBURGH (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0977815-A1 | ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND $i(IN VIVO) IMAGING AND PREVENTION OF AMYLOID DEPOSITION | UNIVERSITY OF PITTSBURGH (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998047969-A1 | ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION | UNIVERSITY OF PITTSBURGH (US) | 1998-10-29 | — | — | WO | disclosed |